The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 5836 -5845
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0802999

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Fits, L.
Right arrow Articles by Lubberts, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Fits, L.
Right arrow Articles by Lubberts, E.

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1

Leslie van der Fits2,*,{dagger}, Sabine Mourits*,{dagger}, Jane S. A. Voerman{dagger}, Marius Kant*,{dagger}, Louis Boon§, Jon D. Laman{dagger}, Ferry Cornelissen{dagger},{ddagger}, Anne-Marie Mus{dagger},{ddagger}, Edwin Florencia*,{dagger}, Errol P. Prens3,*,{dagger} and Erik Lubberts3,{dagger},{ddagger}

Departments of * Dermatology, {dagger} Immunology, and {ddagger} Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands; and § Bioceros BV, Utrecht, The Netherlands

Topical application of imiquimod (IMQ), a TLR7/8 ligand and potent immune activator, can induce and exacerbate psoriasis, a chronic inflammatory skin disorder. Recently, a crucial role was proposed for the IL-23/IL-17 axis in psoriasis. We hypothesized that IMQ-induced dermatitis in mice can serve as a model for the analysis of pathogenic mechanisms in psoriasis-like dermatitis and assessed its IL-23/IL-17 axis dependency. Daily application of IMQ on mouse back skin induced inflamed scaly skin lesions resembling plaque type psoriasis. These lesions showed increased epidermal proliferation, abnormal differentiation, epidermal accumulation of neutrophils in microabcesses, neoangiogenesis, and infiltrates consisting of CD4+ T cells, CD11c+ dendritic cells, and plasmacytoid dendritic cells. IMQ induced epidermal expression of IL-23, IL-17A, and IL-17F, as well as an increase in splenic Th17 cells. IMQ-induced dermatitis was partially dependent on the presence of T cells, whereas disease development was almost completely blocked in mice deficient for IL-23 or the IL-17 receptor, demonstrating a pivotal role of the IL-23/IL-17 axis. In conclusion, the sole application of the innate TLR7/8 ligand IMQ rapidly induces a dermatitis closely resembling human psoriasis, critically dependent on the IL-23/IL-17 axis. This rapid and convenient model allows further elucidation of pathogenic mechanisms and evaluation of new therapies in psoriasis.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 J.S.A.V. and J.D.L. are supported by the Dutch MS Research Foundation. F.C., A.-M.M., and E.L. are supported by the Dutch Arthritis Foundation.

2 Address correspondence and reprint requests to Dr. Leslie van der Fits, Department of Dermatology, Room T02-32, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E-mail address: L.vanderfits{at}lumc.nl

3 E.P.P. and E.L. contributed equally to this work.

4 Abbreviations used in this paper: IMQ, imiquimod; DETC, {gamma}{delta}-positive dendritic epidermal T cells; KO, knockout; LC, Langerhans cells; pDC, plasmacytoid dendritic cells; WT, wild type.




This article has been cited by other articles:


Home page
NEJMHome page
C. B. Salem, H. Hmouda, K. Bouraoui, F. O. Nestle, D. Kaplan, and J. Barker
Psoriasis
N. Engl. J. Med., October 22, 2009; 361(17): 1710 - 1710.
[Full Text] [PDF]


Home page
NEJMHome page
F. O. Nestle, D. H. Kaplan, and J. Barker
Psoriasis
N. Engl. J. Med., July 30, 2009; 361(5): 496 - 509.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.